Asia-Pacific property and retail group Metro Holdings through its subsidiary Metro ARC Investments is buying a 10% interest in DocMed, the digital health arm of Singaporean consumer healthcare group Hyphens Pharma, for SG$6 million ($4.3 million).
The investment will represent a Series A funding for DocMed, later raising its valuation to SG$60 million ($43.5 million) based on the subscription...
NDR Medical launches Japan office
Singaporean medical device maker NDR Medical has opened a new office in Tokyo, Japan, its fourth location in Asia-Pacific. The company also operates in China and Malaysia.
Alongside its opening, the company will also conduct a multi-site trial for its Automated Needle Targeting with X-ray (ANT-X) system with two Japanese university hospitals. The trial is...
Specialty pharmaceutical and consumer healthcare company Hyphens Pharma has formally launched Singapore's first Health Sciences Authority-approved digital pharmacy.
WHAT IT DOES
Hyphens Pharma is engaged in three business segments: specialty pharma, proprietary brands, and medical hypermart and digital. It has established its presence across major Southeast Asian countries, including Singapore,...
